AGGRESSIVE VARIANT PROSTATE CARCINOMA

Clinical trials for AGGRESSIVE VARIANT PROSTATE CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new AGGRESSIVE VARIANT PROSTATE CARCINOMA trials appear

Sign up with your email to follow new studies for AGGRESSIVE VARIANT PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 2

New drug trial targets deadly prostate cancer variant

Disease control Not yet recruiting

This study is testing an experimental pill called zanzalintinib for men with a particularly aggressive and difficult-to-treat form of advanced prostate cancer that has spread. The main goal is to see if the drug can slow or stop the cancer's growth and improve survival. About 30 …

Matched conditions: AGGRESSIVE VARIANT PROSTATE CARCINOMA

Phase: PHASE2 • Sponsor: Deepak Kilari • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

AGGRESSIVE VARIANT PROSTATE CARCINOMA

Get alerted when new AGGRESSIVE VARIANT PROSTATE CARCINOMA trials appear

New drug trial targets deadly prostate cancer variant